Market research to gain the competitive edge
Home
About Us
Services
Industry Insights
Reports

CMO Pricing            

Practices

HTS Strategies

Contract    

BioManufacturing

History of HTS

Directory of      

Contractors

Clients
Press Releases
Contact Us
Industry Reports
HighTech Business Decisions currently has the following published reports available:

High Throughput Screening 2010: Effective Strategies, Innovative Technologies, and Use of Better Assays

This 1050-page report, with over 300 charts and tables, documents current HTS practices for drug discovery and the evolving role of the HTS laboratory in biotech and pharmaceutical companies, academic centers, and institutes worldwide. This study provides an in-depth analysis of the current levels of success as regards to discovering new drugs using HTS, evolving strategies to increase this success, current and expected use of cell-based assays and high content screening, detection technologies, equipment used, targets and target classes growing in importance, the number of compounds screened, throughput, microplates, budgets and expenditures by product category, outsourcing trend, market size and expected growth, unmet needs in HTS, and the challenges and opportunities in HTS for both users and their suppliers.
Published February 2010.

>>Table of Contents >> Order Form
 
Biopharmaceutical Contract Manufacturing 2009:
Expanding Markets, New Capacities and Improved Performance
This 900-page report, the comprehensive 2009 industry study, provides the latest information on biomanufacturing strategies, markets, outsourcing, capacity utilization, contractor relationships, new technologies including proprietary expression systems and media, disposable bioreactors, and challenges ahead for the industry. The data and the analysis in this report are based on 77 in-depth interviews conducted with biomanufacturing directors at pharmaceutical and biotechnology companies and contractor companies worldwide. The analysis of these perspectives and insights allow readers to make the most successful strategic decisions. This report includes 290 summary data tables and charts, and is the most comprehensive and current industry report on biopharmaceutical contract manufacturing. Published June 2009. 
>> Table of Contents   >> Order Form
 
2009 Directory of Biopharmaceutical Contract Manufacturers
Contract manufacturing services for biopharmaceutical production are increasingly in demand as a consequence of numerous biotechnology products in the pipeline and changes in FDA regulations. The directory provides a thorough listing of 102 contractors worldwide, including information on Type of Services Offered, Equipment Capacity, cGMP Certification by Service Category and more.
>>Table of Contents   >> Order Form
 

Biopharmaceutical Contract Manufacturing: Best Practices Pricing Study 2008

This 300-page report documents pricing practices, policies, agreements, and strategies for both pharmaceutical and biotechnology companies and contract manufacturers. Learn what pharmaceutical and biotechnology companies are paying contractors for mammalian cell culture, microbial fermentation production, and related services. Per- batch, per time-in-facility, and per-gram prices are analyzed by technology and by tank sizes and both prices paid and prices charged are documented. In addition, the study provides detailed best practices information regarding difficult-to-negotiate issues such as liability for failed batches, down payments, cancellation fees, technology transfer fees, client-caused delays, process development fees, and a lot more. Published September 2008.

>>Table of Contents >> Order Form
 
 
The History of High Throughput Screening for Drug Discovery: 1998-2005

HighTech Business Decisions (HTBD) has conducted six market research studies and published six comprehensive industry reports on high throughput screening (HTS) since 1998. This report is specifically designed to understand the changes that have occurred in HTS since 1998, how accurate HTS directors have been in forecasting and predicting their use of technology and future needs, how HTS practices have evolved, and the success of HTS as a drug discovery tool. Topics include the number of disease targets screened, target types, assay types, detection modes, microplate formats, outsourcing, and other issues impacting HTS operations and success. The complete analysis, based on both user and supplier primary research, includes market size and growth, major players, user strategies and requirements, documentation of success in drug discovery, trends and technologies, and respondents’ perceptions regarding the future of HTS.

>>Table of Contents   >> Order Form
x


info@HighTechDecisions.com